U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304713) titled 'Probiotic Intervention for People With Multiple Sclerosis' on Nov. 28.
Brief Summary: The goal of this single-arm, mixed methods trial is to learn if it is feasible and acceptable to take a probiotic for 12-weeks in people with Multiple Sclerosis. The main question[s] it aims to answer [is/are]:
* Is it feasible and acceptable for people with MS to take a probiotic for 12-weeks?
* Explore impact on health outcomes? Participants will.
* Drink 70ml probiotic drink daily as prescribed for 12-weeks.
* All data collection will be done remotely.
* Before and after 12-weeks participants will complete an online questionnaire (Acceptabi...